Walleye Trading
GHDX

Walleye Trading’s Genomic Health, Inc. GHDX Stock Holding History

Walleye Trading’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,710
Closed -$190K – 5716
2018
Q3 		$190K Sell
2,710
-3,330
-55% -$195K ﹤0.01% 3798
2018
Q2 		$304K Buy
+6,040
New +$240K ﹤0.01% 3279
2016
Q3 		– Sell
-3,000
Closed -$78K – 5711
2016
Q2 		$78K Buy
+3,000
New +$79.7K ﹤0.01% 3699
2016
Q1 		– Sell
-1,300
Closed -$46K – 6066
2015
Q4 		$46K Buy
+1,300
New +$34.8K ﹤0.01% 3921

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Walleye Trading's GHDX Position: Q4 2018 in Review

Walleye Trading sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 2,710 shares — an estimated $190K sold.

Walleye Trading first reported a position in GHDX in Q4 2015 and held it in 4 quarters. The position peaked at $304K in Q2 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Walleye Trading reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 2,710 Genomic Health, Inc. shares in Q4 2018, an estimated $190K.
  • Walleye Trading first reported a position in Genomic Health, Inc. in Q4 2015 and held it in 4 quarters.
  • Walleye Trading's Genomic Health, Inc. position peaked at $304K in Q2 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.